Superior Accuracy of Aspergillus Plasma Cell-Free DNA Polymerase Chain Reaction Over Serum Galactomannan for the Diagnosis of Invasive Aspergillosis
Clinical Infectious Diseases · 11.11.2023 · 77 (9) · 1282-1290
DOI: 10.1093/cid/ciad420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 14.07.2023. Verfasst von Jordan Mah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Aspergillosis, Invasive Fungal Infections, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background
Invasive aspergillosis (IA) in immunocompromised hosts carries high morbidity and mortality. Diagnosis is often delayed because definitive diagnosis requires invasive specimen collection, while noninvasive testing with galactomannan is moderately accurate. Plasma cell-free DNA polymerase chain reaction (cfDNA PCR) represents a novel testing modality for the noninvasive diagnosis of invasive fungal disease (IFD). We directly compared the performance of Aspergillus plasma cfDNA PCR with serum galactomannan for the diagnosis of IA during routine clinical practice.
Methods
We conducted a retrospective study of all patients with suspected IFD who had Aspergillus plasma cfDNA PCR testing at Stanford Health Care from 1 September 2020 to 30 October 2022. Patients were categorized into proven, probable, possible, and no IA based on the EORTC/MSG definitions. Primary outcomes included the clinical sensitivity and specificity for Aspergillus plasma cfDNA PCR and galactomannan.
Results
Overall, 238 unique patients with Aspergillus plasma cfDNA PCR test results, including 63 positives and 175 nonconsecutive negatives, were included in this study. The majority were immunosuppressed (89.9%) with 22.3% 30-day all-cause mortality. The overall sensitivity and specificity of Aspergillus plasma cfDNA PCR were 86.0% (37 of 43; 95% confidence interval [CI], 72.7–95.7) and 93.1% (121 of 130; 95% CI, 87.4–96.3), respectively. The sensitivity and specificity of serum galactomannan in hematologic malignancies/stem cell transplants were 67.9% (19 of 28; 95% CI, 49.3–82.1) and 89.8% (53 of 59; 95% CI, 79.5–95.3), respectively. The sensitivity of cfDNA PCR was 93.0% (40 of 43; 95% CI, 80.9–98.5) in patients with a new diagnosis of IA.
Conclusions
Aspergillus plasma cfDNA PCR represents a more sensitive alternative to serum galactomannan for noninvasive diagnosis of IA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pathology, Stanford University School of Medicine, Stanford, California, USA.
- Clinical Microbiology Laboratory, Stanford Health Care, Stanford, California, USA.
- Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Jordan Mah, Niaz Banaei
Zitieren
APA
Mah, J., Nicholas, V., Tayyar, R., Moreno, A., Murugesan, K., Budvytiene, I., & Banaei, N. (2023). Superior Accuracy of Aspergillus Plasma Cell-Free DNA Polymerase Chain Reaction Over Serum Galactomannan for the Diagnosis of Invasive Aspergillosis. Clinical Infectious Diseases, 77(9), 1282-1290. https://doi.org/10.1093/cid/ciad420
Vancouver
Mah J, Nicholas V, Tayyar R, Moreno A, Murugesan K, Budvytiene I, et al. Superior Accuracy of Aspergillus Plasma Cell-Free DNA Polymerase Chain Reaction Over Serum Galactomannan for the Diagnosis of Invasive Aspergillosis. Clinical Infectious Diseases. 2023;77(9):1282-1290. doi:10.1093/cid/ciad420
BibTeX
@article{Mah2023,
author = {Mah, Jordan and Nicholas, Veronica and Tayyar, Ralph and Moreno, Angel and Murugesan, Kanagavel and Budvytiene, Indre and Banaei, Niaz},
title = {Superior Accuracy of Aspergillus Plasma Cell-Free DNA Polymerase Chain Reaction Over Serum Galactomannan for the Diagnosis of Invasive Aspergillosis},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {77},
number = {9},
pages = {1282--1290},
doi = {10.1093/cid/ciad420}
}
EUVIMED